Questions About Cancer? 1-800-4-CANCER

Featured Clinical Trials

Highlighted NCI-Supported Cancer Studies

Melanoma - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

  • First-in-Humans Study of New Immunotherapy Agent
    (Posted: 01/24/2012) - In this first-in-humans clinical trial of interleukin-15 (IL-15), patients with metastatic melanoma or metastatic renal cell cancer who have not benefited from other therapies will be given IL-15 by intravenous injection once a day for 12 days.
  • Testing Adjuvant Ipilimumab in Advanced Melanoma
    (Posted: 10/04/2011) - In this clinical trial, patients with stage III or stage IV melanoma that has been completely resected will be randomly assigned to receive adjuvant (post-surgical) treatment with either ipilimumab or high-dose interferon alfa-2b, the current standard of care.
  • Targeted Treatment for Advanced Solid Tumors
    (Posted: 12/16/2008) - This clinical trial combines the drug dasatinib with the angiogenesis inhibitor bevacizumab for patients with metastatic or unresectable solid tumors.
  • Chemotherapy for Inoperable Liver Metastases from Ocular Melanoma
    (Posted: 11/30/2004, Updated: 06/13/2008) - In this study, researchers are testing a procedure called hyperthermic isolated hepatic perfusion to treat inoperable liver metastases secondary to ocular melanoma.
  • Combination Therapy for Advanced Melanoma
    (Posted: 11/01/2005, Updated: 04/24/2008) - In this clinical trial, researchers are testing chemotherapy with the drugs carboplatin and paclitaxel in combination with a new drug called sorafenib (BAY 43-9006) in patients with advanced melanoma.
1 2 3  Next >